Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT03737682
Other study ID # CEBD-CU-2018-10-31
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date July 30, 2019
Est. completion date December 2020

Study information

Verified date July 2019
Source Cairo University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Assessment of pulp inflammation by hemostasis achievement after pulp exposure


Description:

The possibility has been raised of diagnosing pulpal pathological status using the cytokines that are released during the inflammation process in healthy as well as infected tooth pulp. Cytokines are small polypeptides secreted by leucocytes and other inflammatory cells and are known to play important roles in the intensity and duration of the immune response


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 41
Est. completion date December 2020
Est. primary completion date December 2019
Accepts healthy volunteers No
Gender All
Age group 5 Years to 7 Years
Eligibility Inclusion Criteria:

1. healthy children

2. patients had not used any inflammatory medications

3. primary molar teeth of these children were included based on the following clinical and radiographic criteria:

1. no clinical symptoms or evidence of pulp degeneration (pain on percussion, history of swelling or sinus tract

2. no spontaneous pain

3. no radiographic signs of internal or external resorption, widened periodontal ligament space, or furcal/periapical radiolucency

4. physiological root resorption of no more than one third the root length

5. a deep caries lesion with a likelihood of pulp exposure during caries removal

Exclusion Criteria:

- patients used any anti-inflammatory medication

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
ENzyme linked immunity-sorbet assays
Hemostasis achievement reflecting inflammatory status of the pulp based on cytokine levels

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Cairo University

Outcome

Type Measure Description Time frame Safety issue
Primary Measuring interleukin 2 (IL-2) to measure cytokines levels after coronal pulpal removal After 5 minutes
Secondary Measuring interleukin 6 (IL-6) and interleukin 8 (IL-8) to measure cytokines levels after coronal pulpal removal After 5 minutes
Secondary Postoperative pain, Bifurcation/periapical radiolucency and Internal/external root resorption Or other pathological changes To assess postoperative pain by verbal questioning and To observe presence or absence of radiolucency and root resorption or pathological condition 3,6,9,12 months
See also
  Status Clinical Trial Phase
Completed NCT02815670 - Reversal Dabigatran Anticoagulant Effect With Idarucizumab Phase 3
Completed NCT04588350 - Clinical Investigation Evaluating a New Autotransfusion Device in Cardiac Surgery N/A
Recruiting NCT02972385 - Pharmacogenomics of Warfarin in Hispanics and Latinos
Completed NCT02554006 - Predischarge Bundle to Minimize Negative Impact on Quality of Life of Nuisance Bleedings N/A
Completed NCT02569606 - Transfusion and Coagulation Management in Trauma Patients After the Introduction of a Coagulation Algorithm
Recruiting NCT02446730 - Efficacy and Safety of BiomatrixTM Stent and 5mg-Maintenance Dose of Prasugrel in Patients With Acute Coronary Syndrome Phase 4
Completed NCT01935427 - Comparison of Compensatory Reserve Index to Intravascular Volume Change and Stroke Volume N/A
Completed NCT01955720 - Safety, Tolerability, PK and PD of BI 655075 and Establishment of BI 655075 Dose(s) Effective to Reverse Prolongation of Blood Coagulation Time by Dabigatran Phase 1
Recruiting NCT01709786 - Non-Invasive Hemoglobin Monitoring in Patients With Hemorrhage N/A
Completed NCT01191554 - Dose-ranging Study of Tranexamic Acid in Valve Surgery N/A
Completed NCT01136590 - Multicenter, Randomized Placebo-controlled Clinical Trial to Evaluate the Effect of Perioperative Use of Tranexamic Acid on Transfusion Requirements and Surgical Bleeding in Major Spine Surgery Phase 4
Completed NCT01210417 - Trauma Heart to Arm Time N/A
Completed NCT01085006 - The Effect of Tranexamic Acid on Postpartum Hemorrhage During and After Cesarean Delivery Phase 1/Phase 2
Completed NCT00700141 - Non-Interventional Study About Treatment of Hemorrhages in Thyroid Surgery With TachoSil® N/A
Completed NCT00375466 - Tranexamic Acid, Hemorrhage and Transfusions After Combined Aortic Valve Replacement and Coronary Artery Bypass Surgery. N/A
Completed NCT00147420 - RCT of Zhi Byed 11 (ZB11) Versus Misoprostol in Tibet N/A
Completed NCT00479362 - Anticoagulant Therapy During Pacemaker Implantation Phase 4
Recruiting NCT05945680 - Tranexamic Acid in Breast Esthetic Surgery. Phase 4
Completed NCT03273322 - Assessment of Dual Antiplatelet Therapy Versus Rivaroxaban In Atrial Fibrillation Patients Treated With Left Atrial Appendage Closure Phase 2/Phase 3
Withdrawn NCT05672407 - The Role of Local Tranexamic Acid on Periorbital Oculoplastic Surgery Phase 4